BIOHARVEST SCIENCES INC.

Listed Company
BHSTCIK 0001723464NasdaqEmerging GrowthPharmaceutical PreparationsA1CAFY ends Dec 31
Period
FY 2025
Revenue
$34.51M
Net Income
$-11.13M
Total Assets
$47.66M
Equity
$25.45M
Shares Out
22.67M
Op. Cash Flow
$-7.23M

Business

BioHarvest Sciences Inc. is a biotechnology company that develops and manufactures plant-cell-based active ingredients using its Botanical Synthesis Platform Technology to produce concentrated, non‑GMO plant cells at industrial scale. It offers VINIA® red grape cell products (powder, capsules, coffee pods, tea) and is developing additional cell‑based ingredients (olive, pomegranate), while providing CDMO development and manufacturing services for plant‑based active molecules. The company is organized into two business units: the Products Business Unit (nutraceuticals and cosmeceuticals) and the CDMO Services Business Unit. BioHarvest sells direct-to-consumer via its e-commerce sites and marketplaces and distributes products and services in the United States, Canada and Israel.

Summary from filing dated 2025-03-31

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue$34.51M
Net income$-11.13M
Total assets$47.66M
Total liabilities
Stockholders' equity$25.45M
Operating cash flow$-7.23M

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro